Логин: Пароль: ?
 
Продукты питания Ткань, одежда, обувь, постельное белье, текстиль Строительные материалы Бумага, пластик, промтовары Биотопливо Продукция для сельского хозяйства, зоотовары Косметика, средства гигиены Медицинские товары и препараты, лекарства Иное

 

 

 

 

 

 

 

Новости/Аналитика

USA CBD market

17.03.2021

CBD product sales in the United States

The volume of sales of hemp products rich in therapeutically active elements (primarily cannabiol) through hemp dispensaries will reach $ 5.3 billion by 2024, retail sales of similar products through wholesale and retail stores will reach values ​​of $ 12.6 billion, and pharmaceuticals made from the leaves and inflorescences of the plant and sold through pharmacy chains will reach the $ 2.2 billion mark.

On the pages of the specialized electronic edition of Ukrainian cannabis growers, the “Trends in the growth of the global market for hemp nutraceuticals” have already been partially analyzed on the basis of materials provided to the editorial office of one of the American consulting companies. For comments on the published information, the editors turned to the specialists of the information and analytical platform Hemp Consulting. Agreeing with the general conclusions made in the previously published editorial materials, we were provided for use with data prepared on the above topics by research organizations in Canada and the United States. In connection with the previously reached agreement, the data provided by Hemp Consulting specialists are published without any changes / additions by the editorial staff. 

The 2014 Agriculture Law provided an opportunity to “launch” pilot programs for cannabis growers, which led to the proliferation of plant-derived CBD products throughout the country. It is from this period that legal hemp dispensaries in the United States have noted the keenest consumer interest in products that contain therapeutically active elements of the hemp plant, primarily cannabidiol. The steady demand for dispensary-marketed hemp products is the largest source of revenue for the US CBD industry today. 

Amendments to the Law on Farms, adopted in December 2018, allowed not only the commercialization of cannabis cultivation, but also provided opportunities for the sale of CBD products obtained from a plant in the dried straw of which the amount of tetrahydrocannabinol does not exceed 0.3%. Despite this, at the moment the use of plant CBD as food / dietary / dietary supplements at the federal level is still not regulated.

On May 31, 2019, the US Food and Drug Administration held a hearing aimed at collecting information that should form the basis of the regulatory framework governing the use of plant-based cannabidiol in the US market.

At the moment, the structure of an extensive legal market for cannabis nutraceuticals has already been formed in the United States, as well as a market for dispensaries selling various products with significant therapeutic potential, which is already estimated at more than a billion dollars. The existing market for hemp nutraceuticals will most likely make it possible to regulate it at the level of the federal regulatory framework, which will lead to a rapid growth of this market precisely due to retail stores, which will dominate precisely in terms of selling CBD products with significant therapeutic potential. It should be borne in mind that the contribution of the market for pharmaceuticals based on the therapeutic properties of the hemp plant on the US CBD market is currently extremely small and this segment of modern cannabis production will not be able to become dominant in the next few years. 

CBD product sales in the United States

According to analysts of the American CBD market, the volume of hemp products, rich in therapeutically active elements (primarily cannabiol), sold through hemp dispensaries by 2024 will reach a level of $ 5.3 billion, retail sales of similar products through wholesale and retail stores will reach values ​​in $ 12.6 billion, and pharmaceuticals made from the leaves and inflorescences of the plant and sold through pharmacy chains will reach the $ 2.2 billion mark.

It makes sense to pay special attention to the therapeutic properties of other hemp ingredients that have significant therapeutic potential. Scientists, together with developers of consumer goods in the United States, are actively working to bring to the market hemp nutraceuticals or other products that contain other therapeutically active elements of the hemp plant (non-narcotic cannabinoids - cannabichromene, cannabidivarin, cannabigerol, cannabivarin; terpenes, terpenoids, finols , flavonoids, etc.).

Commentary of the specialists of the Association "Ukrainian technical hemp"

As much detailed information as possible on the trends in the global market for hemp nutriceptics, as well as an analysis of the markets for therapeutically active products based on the medicinal properties of the hemp plant in individual economically developed countries of the world will be provided for the listeners of the 6th stream of training of the Hemp University within the framework of the round table “ Problems and Prospects the use of therapeutically active elements of hemp as a basis for nutraceuticals, medicinal cosmetics, animal feed or other products with medicinal properties of the plant . "

Потенциал национального рынка каннабиноидных косметических препаратов
17.01.2024

В Украине потребитель готов для выведения на рынок линейки национальной профессиональной CBD косметической продукции

Объявления
Все объявления »
 
 

facebook

telegram

twitter